Home » Uncategorized » Recent Article Published by the David Lab: The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites.

Recent Article Published by the David Lab: The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites.

By in Uncategorized on .

Recent Article Published by the David Lab at UC Davis:

The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites

Journal of Biological Chemistry

Inherited defects in the DNA repair gene MUTYH lead to cancer, proof that MUTYH has a critical role in preventing cancer in normal cells. In a new study from the David Lab, MUTYH is shown to have a new role that implicates it in the response to a common class of chemotherapy drugs, alkylating agents (https://www.jbc.org/content/early/2020/01/30/jbc.RA119.010497).

Cancer cells evolve resistance to chemotherapy drugs by a number of mechanisms, including upregulating DNA repair enzymes such as BRCA1, which helps cancer cells survive DNA damaging chemotherapy agents. Surprisingly, MUTYH does not help repair alkylating agent DNA damage, but instead enhance alkylating agent toxicity. This study uncovers the underlying molecular mechanism of this activity, which involves MUTYH stimulating cells to create more toxic DNA repair intermediates. By uncovering the molecular mechanism, this research suggests that MUTYH has both a role in preventing DNA mutations that cause cancer, and a separate role in helping kill cancer cells that are treated with chemotherapy drugs, thus the loss of MUTYH is a “double-whammy”. Tests to determine if cancer patients have normal versus functionally-deficient MUTYH may alter chemotherapy treatment choices if these results can be generalized to clinical practice. 

Citation:

Raetz, A.G.; Banda, D.M.; Ma, X.; Xu, G.; Rajavel, A.N.; McKibbin, P.L.; Lebrilla, C.B.; David, S.S. The DNA repair enzyme MUTYH potentiates cytotoxicity of the alkylating agent MNNG by interacting with abasic sites. J. Biol. Chem. 2020.

doi: 10.1074/jbc.RA119.010497

Keywords:

#sheiladavid #davidlab #mutyh #thedavidlab #ucdavischemistry #cytotoxicity #alkylatingagent #mnng #dna #dnarepair #muty #ucdavis #chemistry #biologicalchemistry #chembio #journalofbiologicalchemistry

RSS Science Daily News

  • Oxygen discovered in most distant known galaxy March 20, 2025
    Astronomers have detected oxygen in the most distant known galaxy, JADES-GS-z14-0. This record-breaking detection is making astronomers rethink how quickly galaxies formed in the early Universe.
  • From dinosaurs to birds: the origins of feather formation March 20, 2025
    Feathers, essential for thermoregulation, flight, and communication in birds, originate from simple appendages known as proto-feathers, which were present in certain dinosaurs.By studying embryonic development of the chicken, researchers from the University of Geneva (UNIGE) have uncovered a key role of a molecular signalling pathway (the Shh pathway) in their formation. This research provides new […]
  • Why don't we remember being a baby? New study provides clues March 20, 2025
    Though we learn so much during our first years of life, we can't, as adults, remember specific events from that time. Researchers have long believed we don't hold onto these experiences because the part of the brain responsible for saving memories -- the hippocampus -- is still developing well into adolescence and just can't encode […]
  • Tiny musky rat-kangaroos hold the key to explain why 'roos hop March 20, 2025
    To understand why kangaroos hop -- a rarity among animals -- researchers have studied the musky rat-kangaroo (Hypsiprymnodon moschatus), a diminutive marsupial that weighs only 500 grams but is the last living representative of its family and part of a lineage that extends back to before kangaroos evolved their distinctive hopping gait.
  • Anti-amyloid drug shows signs of preventing Alzheimer's dementia March 20, 2025
    An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain […]

Contact:

Dr. Sheila S. David
ssdavid@ucdavis.edu
(530)-752-4280

Department of Chemistry
One Shields Ave.
Davis, CA 95616